Leaflet LEFISYO 5mg / ml oral solution

Product code:
W68758001
Quantity:
1
Indicated for:
severe pain; opioid dependence
Route of administration:
oral
Substance:
levomethadone (analgesic and antipyretic)
ATC
N07BC05 — Nervous system | Drugs used in addictive disorders | Drugs used in opioid dependence

Precautions:

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.

Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.

Levomethadone is a medication primarily used for the treatment of opioid dependence and the management of severe pain. It is an analog of methadone, with similar properties but greater potency.

This medication works by binding to opioid receptors in the brain, reducing withdrawal symptoms and pain. It is administered orally or by injection, and the dosage is adjusted based on the individual needs of the patient.

Side effects may include drowsiness, dizziness, nausea, constipation, or respiratory depression. Long-term use can lead to dependence, which is why treatment must be closely monitored by a specialist.

Patients should avoid alcohol consumption and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before using levomethadone.

General data about LEFISYO 5mg / ml

Substance:
levomethadone
Date of latest medicines list:
01-12-2023
Product code:
W68758001
Concentration:
5mg / ml
Pharmaceutical form:
oral solution
Quantity:
1
Product type:
Generic medicine
Prescription status:
TAB2 — Medicines dispensed with a special medical prescription for narcotic substances, yellow in color.

Marketing authorisation

Manufacturer:
ALKALOID - INT D.O.O. - SLOVENIA
Holder:
ALKALOID - INT D.O.O. - SLOVENIA
Number:
14405/2022/01
Shelf life:
2 years-after packaging for sale

Pharmaceutical forms available for levomethadone